July 25, 2023
Duopharma Biotech, one of Malaysia's biggest pharmaceutical companies, has committed to expanding access to a mobile breast cancer screening device at the community level.
It has signed a distribution deal with the Malaysian unit of US-based femtech company UE LifeSciences to make the iBreastExam device available in primary care clinics across the country.
iBreastExam is a hand-held, radiation-...
July 13, 2023
Causaly, a tech company using AI to interpret large datasets and literature, announced it closed a $60 million Series B round led by ICONIQ Growth.
Marathon Venture Capital, Index Ventures, Pentech Ventures, EBRD and Visionaries Club also participated in the round, as did former chairman and CEO of Johnson & Johnson Alex Gorsky and CEO and cofounder of Datadog Olivier Pomel.
WHAT IT DOES...
July 12, 2023
CVS Caremark, a pharmacy benefit manager and part of CVS Health, announced it is partnering with drug cost and telehealth company GoodRx to launch Caremark Cost Saver, providing Caremark's members access to GoodRx's lower-cost prescription pricing.
Beginning January 1, 2024, Caremark's members can use their existing benefit card at an in-network pharmacy of their choice to automatically have...
June 28, 2023
Mark Cuban Cost Plus Drug Company (MCCPDC) has announced a partnership with male fertility and sexual healthcare company Posterity Health to provide males access to medications to treat infertility, sexual dysfunction and low testosterone.
Posterity Health is a digital male fertility clinic providing access to reproductive urologists who diagnose and treat sexual health and male fertility issues...
June 2, 2023
Mark Cuban Cost Plus Drug Company (MCCPDC) announced that it's working with Coherus Biosciences to sell Yusimry, a biosimilar version of the top-selling drug Humira, at a discounted price.
Yusimry is used to treat several diseases, such as rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, ulcerative colitis, hidradenitis suppurativa, Crohn’s...
June 2, 2023
Healthcare data company ConcertAI announced its expanded partnership with Caris Life Sciences, where the companies will jointly create a database to generate insights to advance precision medicine, clinical trial management and therapeutic development.
ConcertAI is a real-world data and AI company for healthcare providers and life science companies, while Caris Life Sciences offers whole exome...
May 24, 2023
The Michael J. Fox Foundation (MJFF) has announced a partnership with New York-based H1, a healthcare data company, to streamline its search for physicians actively treating Parkinson's disease patients and gather information on patient populations and treatment approaches.
MJFF will utilize H1's Trial Landscape, an AI-enabled platform that uses performance data to gain insights into clinical...
April 28, 2023
Tricog snaps up $9M funding for US expansion
AI-based cardiac diagnosis solution provider Tricog has raised Rs 700 million ($8.5 million) in a Series B2 funding round led by Japanese institutions, Omron and Sony Innovation Fund. The round was also participated by the University of Tokyo Edge Capital, Inventus Partners, and Singapore's SG Innovate.
The startup plans to use its fresh funds for its...
April 25, 2023
Health technology company PicnicHealth, pharma giant Roche and its subsidiary Genentech are expanding their partnership globally to speed up neurological disease research through investments in real-world data.
PicnicHealth allows patients to see their health history and contribute their de-identified medical data to clinical research.
Roche will leverage PicnicHealth's newest real-world...
April 12, 2023
A federal jury found three former executives of health tech company Outcome Health guilty of multiple counts of fraud on Tuesday.
Rishi Shah, cofounder and former CEO, Shradha Agarwal, former president, and Brad Purdy, former chief operating officer and chief financial officer, were convicted for their roles in a $1 billion scheme that defrauded investors and clients, largely pharma companies....